| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.34 | 2e-10 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.31 | 3e-08 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.2 | 5e-08 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-07 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.21 | 9e-07 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.21 | 9e-07 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.29 | 1e-06 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-06 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-06 |